Browsing by Author Shen, Zhi-Xiang
Showing results 1 to 4 of 4
| Issue Date |
Title |
Author(s) |
| 2015 |
Mutations of Epigenetic Modifier Genes as a Poor Prognostic Factor in Acute Promyelocytic Leukemia Under Treatment With All-Trans Retinoic Acid and Arsenic Trioxide |
Shen, Yang;Fu, Ya-Kai;Zhu, Yong-Mei;Lou, Yin-Jun;Gu, Zhao-Hui;Shi, Jing-Yi;Chen, Bing;Chen, Chao;Zhu, Hong-Hu;Hu, Jiong;Zhao, Wei-Li;Mi, Jian-Qing;Chen, Li;Zhu, Hong-Ming;Shen, Zhi-Xiang;Jin, Jie;Wang, Zhen-Yi;Li, Jun-Min;Chen, Zhu;Chen, Sai-Juan |
| 2013 |
Phase II study of chidamide (CS055), a new subtype-selective oral histone deacetylase inhibitor, in patients with relapsed or refractory peripheral T-cell lymphoma |
Shi, Yuan-Kai;Dong, Mei;Hong, Xiao-Nan;Zhang, Wei-Jing;Feng, Ji-Feng;Zhu, Jun;Yu, Li;Ke, Xiao-Yan;Huang, Hui-Qiang;Shen, Zhi-Xiang;Fan, Yun;Li, Wei;Zhao, Xie-Lan;Qiu, Lu-Gui;Huang, He |
| 2013 |
Posaconazole vs. fluconazole as invasive fungal infection prophylaxis in China: a multicenter, randomized, open-label study |
Shen, Yang;Huang, Xiao-Jun;Wang, Jian-Xiang;Jin, Jie;Hu, Jian-Da;Yu, Kang;Wu, De-Pei;Wang, Shu-Jie;Yu, Li;Chen, Xie-Qun;Liu, Ting;Liang, Ying-Ming;Chen, Fang-Ping;Li, Yan;Shen, Zhi-Xiang |
| 2016 |
Switching to nilotinib versus imatinib dose escalation in patients with chronic myeloid leukaemia in chronic phase with suboptimal response to imatinib (LASOR): a randomised, open-label trial |
Cortes, Jorge E.;De Souza, Carmino Antonio;Ayala, Manuel;Lopez, Jose Luis;Bullorsky, Eduardo;Shah, Sandip;Huang, Xiaojun;Babu, K. Govind;Abdulkadyrov, Kudrat;Rodrigues de Oliveira, Jose Salvador;Shen, Zhi-Xiang;Sacha, Tomasz;Bendit, Israel;Liang, Zhizhou;Owugah, Tina;Szczudlo, Tomasz;Khanna, Sadhvi;Fellague-Chebra, Rafi K.;le Coutre, Philipp D. |
